ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 49 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $31,805 | -79.6% | 13,650 | -65.9% | 0.00% | – |
| Q4 2021 | $156,000 | +56.0% | 40,014 | +33.9% | 0.00% | -100.0% |
| Q1 2021 | $100,000 | -82.9% | 29,880 | -90.7% | 0.00% | -88.9% |
| Q2 2020 | $586,000 | +1262.8% | 322,225 | +662.8% | 0.01% | +800.0% |
| Q1 2020 | $43,000 | -68.6% | 42,243 | -35.8% | 0.00% | 0.0% |
| Q2 2019 | $137,000 | +104.5% | 65,848 | +395.1% | 0.00% | 0.0% |
| Q1 2018 | $67,000 | -2.9% | 13,300 | -2.2% | 0.00% | 0.0% |
| Q4 2017 | $69,000 | +7.8% | 13,600 | +32.0% | 0.00% | 0.0% |
| Q3 2017 | $64,000 | +93.9% | 10,300 | -23.1% | 0.00% | 0.0% |
| Q4 2016 | $33,000 | – | 13,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |